Company Analysis

Bioceres Crop Solutions Corp. (BIOX)

Nasdaq: BIOX · Agricultural Chemicals · George Town, Grand Cayman, KY · filing with the SEC since 2019
Grade4.9
◀ Past 5.3● Present 4.7▶ Future 4.8
1 est.
The companyfiscal 2025, as filed
Revenue$335M-27.9%
Net income-$58.8M-907.3%
Earnings per share$-0.88-1388.8%
Operating cash flow$49.9M+19.6%
Cash$32.7M-26.5%
Debtn/a
Shareholders’ equity$295M-16.0%
Shares, diluted63.2M+0.6%
Return on equity-19.9%
The recordfrom its filings
Filings in 202630
Newest filingOct 30 · 20-F
Annual reportOct 30, 2026
Quarterly reportn/a
Next report due20-F by Oct 28
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryAccelerated filer
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
161819202122232425
As filed, in USD. Nothing here is a forecast.

News

Aug 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 4, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton BIOX · research, not advice